Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check4 days agoChange Detected- The study page now shows a 403 Forbidden error page, replacing the study record content. This change prevents viewing the trial details and related information, reflecting a blockage in accessing essential information on the page.SummaryDifference18%

- Check11 days agoChange DetectedFooter revision label updated from v3.6.6 to v3.7.0, indicating a version change of the page components.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew page metadata items were added: Rheumatoid arthritis, related topics, MedlinePlus Genetics, and an updated revision tag Revision: v3.6.6; the previous tag Revision: v3.6.5 was removed.SummaryDifference0.1%

- Check32 days agoChange DetectedAn annotation was added to the 'Other Study ID Numbers' section clarifying that the 2015 identifier corresponds to a U.S. NIH grant/contract.SummaryDifference0.0%

- Check39 days agoChange DetectedThe related topics section no longer includes 'Rheumatoid arthritis' and 'MedlinePlus Genetics'. This change affects how the study is indexed and described in relation to the condition and genetics resources.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a newer document version without changing substantive study details.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.